AMKAYMedical Equipment & Supplies

Amkay Products LtdCash Flow Statement

52.00
-8.46%

Amkay Products Ltd Cash Flow Statement (Annual)

Metric2025202420232022
Free Cash Flow-2.79 Cr-1.39 Cr0.95 Cr-2.40 Cr
Issuance Of Capital Stock12.61 Cr0.000.000.00
Capital Expenditure-2.48 Cr-0.73 Cr-0.02 Cr-2.15 Cr
End Cash Position1.54 Cr0.11 Cr0.05 Cr0.20 Cr
Other Cash Adjustment Outside Changein Cash-1000.00-1000.001000.00
Beginning Cash Position0.11 Cr0.05 Cr0.20 Cr0.92 Cr
Changes In Cash1.43 Cr0.06 Cr-0.15 Cr-0.72 Cr
Financing Cash Flow7.59 Cr0.24 Cr0.26 Cr2.59 Cr
Net Other Financing Charges-1000.001000.000.35 Cr
Interest Paid Cff-0.32 Cr-0.52 Cr-0.45 Cr-0.38 Cr
Net Common Stock Issuance12.61 Cr0.000.000.00
Common Stock Issuance12.61 Cr0.000.000.00
Net Issuance Payments Of Debt-2.82 Cr0.76 Cr0.36 Cr2.97 Cr
Net Short Term Debt Issuance-2.59 Cr2.84 Cr0.48 Cr0.85 Cr
Net Long Term Debt Issuance-0.23 Cr-2.07 Cr-0.12 Cr2.12 Cr
Investing Cash Flow-5.84 Cr0.48 Cr-1.39 Cr-3.07 Cr
Net Other Investing Changes-0.26 Cr-0.43 Cr
Interest Received Cfi0.14 Cr0.03 Cr0.03 Cr0.15 Cr
Net Investment Purchase And Sale-3.25 Cr1.61 Cr-1.57 Cr-1.26 Cr
Sale Of Investment1.03 Cr1.61 Cr
Purchase Of Investment-4.28 Cr
Net PPE Purchase And Sale-2.48 Cr-0.73 Cr-0.02 Cr-2.15 Cr
Purchase Of PPE-2.48 Cr-0.73 Cr-0.02 Cr-2.15 Cr
Operating Cash Flow-0.32 Cr-0.66 Cr0.98 Cr-0.25 Cr
Taxes Refund Paid-1.02 Cr-0.90 Cr-0.51 Cr-1.15 Cr
Change In Working Capital-3.59 Cr-3.41 Cr-1.61 Cr-1.91 Cr
Change In Other Current Liabilities0.13 Cr0.07 Cr-0.08 Cr-0.74 Cr
Change In Other Current Assets-0.05 Cr-53000.000.76 Cr2.00 Cr
Change In Payable0.56 Cr-0.43 Cr-2.05 Cr-1.20 Cr
Change In Inventory-2.51 Cr-3.01 Cr-0.62 Cr-1.70 Cr
Change In Receivables-1.73 Cr-0.04 Cr0.39 Cr-0.27 Cr
Other Non Cash Items0.17 Cr0.49 Cr0.43 Cr0.23 Cr
Depreciation And Amortization0.83 Cr0.56 Cr0.72 Cr0.54 Cr
Depreciation0.83 Cr0.56 Cr0.72 Cr0.54 Cr
Pension And Employee Benefit Expense0.02 Cr0.02 Cr24000.0085000.00
Gain Loss On Investment Securities-1.03 Cr-0.94 Cr-0.35 Cr
Net Foreign Currency Exchange Gain Loss33000.000.02 Cr
Gain Loss On Sale Of PPE-0.03 Cr0.00-0.04 Cr0.00
Net Income From Continuing Operations4.30 Cr3.50 Cr2.34 Cr2.04 Cr

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.